comparemela.com

Latest Breaking News On - சைகடெலிக் ஆய்வுகள் - Page 22 : comparemela.com

What is MDMA: party drug or therapeutic agent?

What is MDMA: party drug or therapeutic agent? At home in both weekend raves and the psychiatric ward, MDMA is not your typical street drug. MDMA in pill form (ecstasy) and powder (molly). Credit: Flickr, Kripos NCIS. MDMA, short for 3,4 methylenedioxymethamphetamine, is a psychoactive drug whose effects can resemble those of both stimulants and psychedelics. The drug is known to produce distortions in time and perception, enhance the enjoyment of sensory experiences, and make people feel more energized. Its defining feature is that it increases self-awareness and empathy, which together enable a feeling of connectedness that many users report. In its tablet or capsule form, MDMA is known as

What Happens When Big Pharma Starts Selling Hallucinogens

May 4, 2021 The popularization of psychedelics has already transformed the American mind. As tripping becomesnormalizedandlegal in the coming decade, the pace of change will only accelerate. There will be more openness to new ideas, both brilliant and insane. Commercial availability will also invigorate the market for synthetic religious experiences. Having seen people gobble up hallucinogens in various contexts, I’m not particularly bothered by the substances themselves. The physical effects are negligible fatality rates are basically zero and many people derive real insight from their use. Certainly, a sizable minority become head-spun wackos, but compared to the utter devastation wrought by opiates, or even alcohol, it’s a peripheral concern.

From High Times, to facing prison, Matt Stang is now the CEO of a psychedelic company

From High Times, to facing prison, Matt Stang is now the CEO of a psychedelic company Stang says he lived through the tipping point with cannabis and something similar is happening with psychedelics. Author of the article: Sam Riches Publishing date: May 03, 2021  •  4 hours ago  •  5 minute read Matt and Jackee Stang, the co-founders of Delic Corp. Photo by Delic Corp Article content This story first appeared in Weekend Dispensary, a weekly newsletter from The GrowthOp. Signup now to get a story delivered to your inbox every Saturday.  In 2010, Matt Stang was facing the possibility of spending the rest of his life in prison.

MDMA Reaches Next Step Toward Approval for Treatment

May 3, 2021Updated 6:55 p.m. ET In an important step toward medical approval, MDMA, the illegal drug popularly known as Ecstasy or Molly, was shown to bring relief to those suffering from severe post-traumatic stress disorder when paired with talk therapy. Of the 90 people who took part in the new study, which is expected to be published later this month in Nature Medicine, those who received MDMA during therapy experienced a significantly greater reduction in the severity of their symptoms compared with those who received therapy and an inactive placebo. Two months after treatment, 67 percent of participants in the MDMA group no longer qualified for a diagnosis of PTSD, compared with 32 percent in the placebo group.

Research finds MDMA can help with PTSD: NYT

Research finds MDMA can help with PTSD: NYT Justine Coleman © Getty Images Research finds MDMA can help with PTSD: NYT A research study involving 90 participants determined that MDMA, commonly known as ecstasy or molly, when paired with talk therapy can help those suffering from post-traumatic stress disorder (PTSD), The New York Times reported on Monday. The study, which was obtained by the Times and has not yet been published, determined that two months after treatment, 67 percent of participants who received MDMA did not qualify for a PTSD diagnosis any more, compared with 32 percent who did not take the drug. The research is expected to be published in Nature Medicine later this month and moves MDMA closer to getting Food and Drug Administration (FDA) authorization for therapeutic use. The FDA would need to analyze another phase three trial showing the benefits of MDMA-assisted therapy for PTSD with approval coming at the earliest in 2023.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.